SCHEMBL7533731

SCHEMBL7533731

Cn1cc(NC(=O)c2cc([N+](=O)[O-])cn2C)cc1C(=O)NCCNC(N)=NO

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HRAS P01112 13/20 0.48
ESR1 P03372 13/20 0.48
ESR2 Q92731 13/20 0.48
TOP1 P11387 2/20 0.48
KDM4E B2RXH2 1/20 0.48
POLB P06746 1/20 0.48
MAPT P10636 1/20 0.48
HIF1A Q16665 1/20 0.48
AR P10275 2/20 0.36
HPSE Q9Y251 1/20 0.36
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC8 Q9BY41 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7533826 1.00 HRAS (0.48) HRASESR1ESR2TOP1KDM4E
SCHEMBL7541176 0.92 AR (0.38) HRASESR1ESR2TOP1KDM4E
SCHEMBL6176129 0.89 HRAS (0.53) HRASESR1ESR2TOP1KDM4E
Hydrochloric Acid SCHEMBL6178110 0.86 KDM4E (0.56) HRASESR1ESR2TOP1KDM4E
Hydrochloric Acid SCHEMBL6178124 0.84 TOP1 (0.55) HRASESR1ESR2TOP1KDM4E
SCHEMBL27279001 0.84 HRAS (0.47) HRASESR1ESR2TOP1KDM4E
SCHEMBL27272956 0.84 HRAS (0.47) HRASESR1ESR2TOP1KDM4E
SCHEMBL27282452 0.84 HRAS (0.47) HRASESR1ESR2TOP1KDM4E
SCHEMBL27275434 0.84 HRAS (0.47) HRASESR1ESR2TOP1KDM4E
SCHEMBL27276235 0.84 HRAS (0.47) HRASESR1ESR2TOP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242374-A1 ACRYLOYL PEPTIDIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS Pharmacia Italia S.p.A. (IT) 2002-09-25 EP disclosed
WO-2001040181-A1 ACRYLOYL PEPTIDIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA S.P.A. (IT) 2001-06-07 WO disclosed